Liquid Biopsy Market Size And Forecast
According to Verified Market Research, the Global Liquid Biopsy Market was valued at USD 691.6 Million in 2018 and is projected to reach USD 2,790.6 Million by 2026, growing at a CAGR of 19.42 % from 2019 to 2026.

The latest survey on Global Liquid Biopsy Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunity available and trend in the Liquid Biopsy Market. The report bridges the historical data from 2013 to 2018 and forecasted till 2026. The report aims to present the analysis of Global Liquid Biopsy Market By Circulating BioMarker, By Application, By End User, By Product & Services, By Clinical Application, By Competitive Landscape,  By Region – North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities.

What is a liquid biopsy?
A liquid biopsy is a non-invasive and simple alternative to the ‘traditional’ or surgical biopsies and involves the sampling and analysis of non-solid biological tissue, primarily blood. Liquid biopsies enable medical professionals to be able to discover several aspects concerning a tumor through a patient’s blood sample. The liquid biopsy facilitates medical professionals to understand which treatments are most likely to work for the patient.

Liquid biopsies are a beneficial alternative to surgical biopsies in the case of patients whose tissue is unable to be biopsied or as an addition in order to comprehensively evaluate drug response. This method also allows for an accurate understanding of the genomic landscape of a tumor, by being able to avoid conventional issues such as intratumor heterogeneity.

 Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=3757&utm_source=Free&utm_medium=004

Global Liquid Biopsy Market Overview
With the advent of technological advancement in the healthcare sector, areas of medicine such as the diagnosis and treatment through progressive technology and minimally invasive procedures have therefore grown significantly as a result. With non-invasive or minimally invasive methods in general, there are several advantages as compared to its counterpart as it involves the drastic increase in overall patient safety as well as leads to enhanced customer satisfaction through decreasing or eliminating the overall patient recovery time.

 As per the above figure, it can be said that the global minimal surgery market will have doubled in size from 2012 to 2019. The growing economies of countries such as India and China whose substantial population itself demands an increase in healthcare. This is driving the increased potential for the growth of the liquid biopsy market.

Moreover, the increasing prevalence of cancer cases is playing a major role in the growth of the liquid biopsy market. The Americas is the major contributor in the liquid biopsy market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the Americas. The rising older population is playing a key role in the increased adoption of liquid biopsy tests. On the other hand, the lack of skilled professionals and a lack of knowledge about liquid biopsy will pose a challenge to the growth of the market at a global level.

Global Liquid Biopsy Market: Segmentation
The Liquid Biopsy market is segmented on the basis of Product and Service, Circulating Biomarker, Cancer Type, End-User and geography.

Liquid Biopsy Market By Cancer Type:
On the basis of Cancer type, the market is bifurcated into Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancers.

 Lung Cancer accounted for the largest market share of 35.34% in 2017 and is projected to grow at the highest CAGR during the forecast period. The frequencies of lung cancer have significantly increased over the last century mainly due to smoking and remain the most frequently diagnosed cancer and the leading cause of cancer-related mortality worldwide. Due to the limitation of tissue biopsy, lung cancer misdiagnoses, inadequate tumor sampling and delayed diagnoses are common factors of the leading deaths. The advent of liquid biopsy technology allows a better understanding of the tumor microenvironment and systematic actions of the tumor and this may allow molecular diagnostic to be done on circulating tumor DNA.

Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=3757&utm_source=Free&utm_medium=004

Liquid Biopsy Market Competetive Landscape:
Liquid Biopsy Market is highly fragmented with the presence of a large number of players globally. Some of the major companies include Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC, Trovagene Inc., Guardant Health Inc., GRAIL, and MDX Health SA.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Obtain Report Details @ https://www.verifiedmarketresearch.com/product/global-liquid-biopsy-market-size-and-forecast-to-2025/?utm_source=Free&utm_medium=004